Market Research Industry Today

Heparin API Global Market in 2024: A Comprehensive Analysis of Opportunities and Threats

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine.
Published 30 April 2024

    Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.

    This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

    The global market for Heparin API was estimated to be worth US$ 2635.1 million in 2023 and is forecast to a readjusted size of US$ 6116.8 million by 2030 with a CAGR of 12.5% during the forecast period 2024-2030

    Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.

    The market driver mainly increasing prevalence of conditions such as renal impairment, coronary artery disease, and venous thromboembolism, High demand for anticoagulants, etc.

    In recent years, with the impact of African swine fever and the outbreak of COVID-19. Heparin as a resource-based industry expected to be in a state of tight supply for a period in the future, and the tight supply state may drive the sales price of heparin products to rise, the future driving force of the industry is more obvious, and the long-term profitability is more certain. The price of heparin has ushered in a major upward cycle since 2016. The main reason is that China is the main supplier of live pigs in the world. The raging African swine fever has greatly reduced the supply of live pigs, driving the price of heparin to rise sharply.

    Asia-Pacific is the largest consumption place, with a revenue market share nearly 35% in 2022. Mainly China is the worlds’ largest pig production, which supplied by sufficient raw materials. Following Asia-Pacific, Europe is the second largest consumption place with the revenue market share nearly 34%.

    The global key manufacturers of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, and etc. In 2022, the global top five players hold a share approximately 57% in terms of revenue.

Global Leading Market Research Publisher QYResearch announces the release of its lastest report “Heparin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”. Based on historical analysis (2019-2023) and forecast calculations (2024-2030), this report provides a comprehensive analysis of the global Heparin API market, including market size, share, demand, industry development status, and forecasts for the next few years. Provides advanced statistics and information on global market conditions and studies the strategic patterns adopted by renowned players across the globe.It aims to help readers gain a comprehensive understanding of the global Heparin API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making. As the market is constantly changing, the report explores competition, supply and demand trends, as well as the key factors that contribute to its changing demands across many markets.

Global Heparin API Market: Driven factors and Restrictions factors

The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the future. The information presented is based on historical milestones and current trends, providing a detailed analysis of the production volume for each type from 2010 to 2030, as well as the production volume by region during the same period.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】

Overall, this report strives to provide you with the insights and information you need to make informed business decisions and stay ahead of the competition.

All findings, data and information provided in the report have been verified and re-verified with the help of reliable sources. The analysts who wrote the report conducted in-depth research using unique and industry-best research and analysis methods.

The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The Heparin API market is segmented as below:

By Company

    Shenzhen Hepalink Pharmaceutical

    Yantai Dongcheng Pharmaceutical

    Nanjing King-friend Biochemical Pharmaceutical


    Hebei Changshan Biochemical Pharmaceutical


    Qingdao Jiulong Biopharmaceutical

    Changzhou Qianhong Biopharma

    Dongying Tiandong Pharmaceutical


    Hubei Enoray Biopharmaceutical

    Yino Pharma

    Cisen Pharmaceutical

    Nanjing Xinbai Pharmaceutical

    Sichuan Deebio Pharmaceutical

Segment by Type

    Heparin Sodium

    Heparin Calcium

Segment by Application



This information will help stakeholders make informed decisions and develop effective strategies for growth. The report's analysis of the restraints in the market is crucial for strategic planning as it helps stakeholders understand the challenges that could hinder growth. This information will enable stakeholders to devise effective strategies to overcome these challenges and capitalize on the opportunities presented by the growing market. Furthermore, the report incorporates the opinions of market experts to provide valuable insights into the market's dynamics. This information will help stakeholders gain a better understanding of the market and make informed decisions.

Each chapter of the report provides detailed information for readers to further understand the Heparin API market:

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Two: Detailed analysis of Heparin API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of Heparin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.

Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Analysis of sales channel, distributors and customers.

Chapter Thirteen: Research Findings and Conclusion.

Our Service:

  1. Express Delivery Report Service
  2. More than 16 years of vast experience
  3. Establish offices in 6 countries
  4. Operation for 24 * 7 & 365 days
  5. Owns large database
  6. In-depth and comprehensive analysis
  7. Professional and timely after-sales service

To contact us and get this report:

About Us:

QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 16 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:

If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States



Tel: 001-626-842-1666(US) 


Other Industry News

Ready to start publishing

Sign Up today!